Thomas Zengeya's Colleagues at NeuBase Therapeutics
Diane Carlisle
Scientific Consultant for Huntington's Disease Preclinical Development
Thomas Zengeya's Contact Details
HQ
N/A
N/A
Location
Company
NeuBase Therapeutics
NeuBase Therapeutics
Thomas Zengeya's Company Details
NeuBase is developing ultra precision genetic medicines targeting rare, monogenic diseases, for which there are no approved therapies, as well as more common genetic disorders, including cancers that are resistant to current therapeutic approaches. NeuBase's pipeline includes therapeutic candidates for the treatment of myotonic dystrophy type 1 (DM1), Huntington's disease (HD), and cancer-driving point mutations in KRAS G12V and G12D, which are involved in many tumor types and have historically been "undruggable."
Frequently Asked Questions about Thomas Zengeya
Thomas Zengeya currently works for NeuBase Therapeutics, Inc.
Thomas Zengeya's role at NeuBase Therapeutics, Inc is Director of Chemistry Research.
Thomas Zengeya's email address is ***@neubasetherapeutics.com. To view Thomas Zengeya's full email address, please signup to ConnectPlex.
Thomas Zengeya works in the Pharmaceuticals industry.
Thomas Zengeya's colleagues at NeuBase Therapeutics are Valentina Caro, Mykaela Wagner, Matthew Koch, James Burrows, Austin Kilgore, Ryan Dyer, Diane Carlisle and others.
Thomas Zengeya's phone number is N/A